FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Monday

 

Andiamo! Moving forward with autologous hematopoietic transplantation for highly active MS
































The cause and exact processes underlying the pathophysiology of multiple sclerosis (MS) development and progression have eluded clinicians and scientists for almost 150 years, since Jean-Martin Charcot recognized it as a distinct disease.
Based on current understanding, an inflammatory immune response, potentially elicited by a common pathogen or unidentified microbial or environmental agent, is inappropriately targeted against CNS components, possibly a myelin protein, and not properly tempered by immune regulatory circuits. Blood-derived T and B cells are critical components of the adaptive immune response that initiates the inflammatory attack, although innate immunity is also implicated, with macrophages and microglia operating as antigen presenting cells, as demyelinating effector cells, and possibly as mediators of a diffuse chronic CNS inflammatory state.

Story Source: The above story is based on materials provided by NEUROLOGY
Note: Materials may be edited for content and length

Labels:



Go to Newer News Go to Older News